Lilly rolls out monthly-dose Zepbound pen to simplify obesity therapy
Eli Lilly introduced a KwikPen that delivers four weekly doses of Zepbound in one monthly injection, priced from $299 per month on LillyDirect, with FDA labeling expanded to include the multi-dose device to support Zepbound’s dominant position in the obesity-drug market.